Market Research Blog

With advent of tissue engineering and improved ability to combine advanced manufacturing technologies with biomaterials and cell culture systems, more biomimetic tissue constructs have been emerged. Technological advancements are leading to production of advanced tissue engineered skin substitutes. 3D bioprinting and biotextile are emerging as popular biofabrication strategies for creating bioengineered skin substitutes. A team of researchers in the U.S. recently discovered a technology for complete 3D printing of the living skin along with blood vessels. Emergence of such revolutionary fabrication technologies will create a massive opportunity in the global market.

Despite breakthrough innovations assisting the growth of market, certain limitations are still there. The inability of tissue engineered skin substitutes to produce skin appendages such as hair follicles, sebaceous glands, and nails continues to remain among the most concerning challenges facing R&D teams

To remain ahead of your competitors, request for a sample – https://www.futuremarketinsights.com/reports/sample/rep-gb-781

Key Takeaways – Tissue Engineered Skin Substitute Market Study

• With increasing researches in tissue engineering, the demand for   biologic skin substitute is expected to increase in the forecast period. For instance, a team of engineers at the California Institute of Technology (Caltech) and ETH Zurich have developed an artificial skin made from pectin, a naturally occurring long-chain molecule present in plant cell walls allowing the construction of natural and new dermis.
• Increasing prevalence of diabetes and chronic wounds is boosting the demand for tissue engineered skin substitutes.
• The demand for tissue engineered skin substitutes in emerging economies such as China and India is expected to increase owing to increasing incidence of diabetic foot ulcers, venous leg ulcers, and pressure ulcers.

Leading Manufacturers Setting the Pace for Product Innovations

The tissue engineered skin substitute market is a consolidated market. The tier 1 companies in the tissue engineered skin substitute market such as Allergan Plc., Mimedex Group Inc., Integra LifeSciences Corp. and Integra LifeSciences Corp. are expected to hold more than half of the total revenue generated by tissue engineered skin substitutes. The key players in the market are reshaping their current product portfolio by focusing on the introduction of new and advanced technologies and innovating new products.

Seeking More Insights?

Tissue engineered skin substitute market, a new study from Future Market Insights, opines on the evolution of tissue engineered substitute market from 2014 – 2021 and presents demand projections from 2022 – 2029 on the basis of; product (acellular skin substitute, biologic skin substitute, cellular skin substitute and synthetic substitute), material (synthetic and natural), application (chronic wound, acute wound and other applications such as breast reconstruction etc.) and end user (hospital, specialty clinics, ambulatory surgical centres and research laboratories) across seven prominent regions.

Get a Tailored Made Report to Match Your requirements, Ask from Market Research Expert – https://www.futuremarketinsights.com/ask-question/rep-gb-781

Tissue Engineered Skin Substitute Market by Category By Product:

• Acellular Skin Substitutes
  • Acellular skin substitutes based on Amniotic Membrane
  • Other Acellular skin substitutes
• Biologic Skin Substitute
  • Allograft
  • Xenograft
• Cellular Skin Substitutes
  • Cellular skin substitute based on amniotic membrane
  • Other cellular skin substitutes

• Synthetic Skin Substitutes

By Material:

• Synthetic
• Natural

By Application:

• Chronic Wounds
  • Venous leg Ulcers
  • Diabetic Foot Ulcer
  • Pressure Ulcers
• Acute Wounds
  • Traumatic Wounds
  • Burn Cases
• Other Applications

For in-depth competitive analysis, Buy Now – https://www.futuremarketinsights.com/checkout/781

By End User:

• Hospital
• Specialty Clinics
• Ambulatory Surgical Centers
• Research Laboratory

By Region:

• North America
• Latin America
• Europe
• South Asia
• East Asia
• Oceania
• Middle East and Africa (MEA)

Molecular imaging targets molecular pathways and mechanisms associated with a particular disease present inside a living body. It enables to study of the molecular abnormalities taking place inside the body to carry out early detection of disease and to optimize medications aiming for disease-related molecular targets. Nuclear medicine plays a vital role in conducting a molecular imaging process and can be broadly used for the treatment of distinct cancer and related diseases.

To remain ahead of your competitors, request for a sample – https://www.futuremarketinsights.com/reports/sample/rep-gb-724

Clinical molecular imaging is trending towards hybrid modalities such as PET-CT, SPECT, or PET-MR that provide high-resolution anatomical imaging. PET-CT is anticipated to gain maximum revenue share over the forecast period, and the segment is projected to expand at a CAGR of 16.3% during the forecast period.

Molecular imaging has evolved as a promising tool for early detection of cancers and cardiac diseases, providing a more complete picture of the tumor genome, as well as monitoring tumor emergence during disease. Molecular imaging provides the ability to accurately evaluate biological responses to the treatment of individual patients over time, opening the door to personalized medical techniques directed by molecular imaging reporters.

Key Takeaways from Molecular Imaging Market Study

• Molecular imaging market will register accelerating demand, enabling a y-o-y growth of nearly 11% in 2021
• Backed by presence of a state-of-the-art healthcare infrastructure, the U.S. accounts for nearly 65% sales in North America
• Driven by rising cases of cancer, the  U.K. market will exhibit above 14% y-o-y growth in 2021
• Government initiatives aimed at offering advanced medical care will enable growth in Germany and France
• The market in China is expected to surge at a CAGR of over 10% from 2021 to 2031

 “Increasing research & development activities in cancer-specific drug discovery and other chronic diseases are expected to boost demand for molecular imaging. Besides this, as a result of increasing incidence of cancer the demand for highly sensitive and precise diagnostic for better treatment solutions is increasing,” says a Future Market Insights analyst.

Molecular Imaging Needs Rising In Response to Increasing Cancer Cases

According to the World Health Organization (WHO) in 2020, breast cancer emerged as the most common type of cancer, affecting 2.2 million people around the world.  Lung cancer has been the leading cause of death with over 1.7 Mn of total deaths in 2020. North America has the highest incidence rate of cancer followed by East Asia. This rise in the cancer population is leading to a rise in the demand for diagnostic imaging, thereby catalyzing the demand for molecular imaging.

Get a Tailored Made Report to Match Your requirements, Ask from Market Research Expert – https://www.futuremarketinsights.com/ask-question/rep-gb-724

Who is Winning?

Key players in the molecular imaging market are keenly focusing on carrying out strategic activities such as acquisitions, collaborations, and mergers, product launch, global expansion to create a strong position in the market is leading to vigorous developments which are helping the market to grow at a considerable rate.

• For instance, in 2019, Bruker Corporation launched a benchtop magnetic resonance spectrometer with a high-field 9.4 Tesla small animal MRI system with integrated in-line PET. Thus strengthening its product portfolio.

Strategies adopted by key players are often intended at global expansion. They largely  focus on product launches and mergers & acquisitions. There have been a few strategic partnerships among leading players to enhance the product line and better facilities for end-user.

• In September 2020, Bruker Corporation announced the acquisition of Canopy Biosciences, LLC. This acquisition enhances Bruker’s offering in targeted multi-omics and fluorescence-based imaging techniques.

Some of the key players are Key market players covered by Future Market Insights in the report are is Hermes Medical Solutions, Bruker Corporation, GE Company,  Fujifilm Holdings Corp.,  Koninklijke Philips N.V.,  Siemens AG,  Toshiba Medical System Corp.,  Mirada Medical Limited,  Carestream Health, Inc.,  Esaote SpA, Positron Corporation,  Medisco Ltd.,  Hitachi Medical Corp.,  MIM Software Inc.

Want more insights?

Future Market Insights brings the comprehensive research report on forecasted revenue growth at global, regional, and country levels and provides an analysis of the latest industry trends in each of the sub-segments from 2016 to 2031. The global molecular imaging market is segmented in detail to cover every aspect of the market and present a complete market intelligence approach to the reader. The study provides compelling insights based on a modality (Positron Emission Tomography (PET), Positron Emission Tomography- Computed Tomography (PET-CT), Positron Emission Tomography- Magnetic Resonance (PET-MR), Single Photon Emission Computed Tomography (SPECT), Software, Magnetic Resonance Spectroscopy, Molecular Ultrasound Imaging), Application (Cardiology, Oncology, Gastrointestinal Disorders, Neurology Disorders, Others) and end-user ( Hospitals, Ambulatory Surgical Centers, and Diagnostic Centers), across seven major regions of the world.

For in-depth competitive analysis, Buy Now – https://www.futuremarketinsights.com/checkout/724

Molecular Imaging Market by Category Modality

• Positron Emission Tomography (PET)
• Positron Emission Tomography- Computed Tomography (PET-CT)
• Positron Emission Tomography- Magnetic Resonance (PET-MR)
• Single Photon Emission Computed Tomography (SPECT)
• Software
  • On Premises Solutions
  • Cloud Based Solutions
• Magnetic Resonance
• Molecular Ultrasound Imaging

Application

• Cardiology
• Oncology
• Gastrointestinal Disorders
• Neurology Disorders
• Others

 End User

• Hospitals
  • 500+ Beds
  • 200-499 Beds
  • Less than 200 Beds
• Ambulatory Surgical Centres
• Diagnostic Centres

Key Highlights

• Personnel screening systems remain highly sought-after in security inspection applications to minimize internal threats
• Aviation sector accounts for greater security inspection product and service adoption through 2030
• Portable security inspection models continue to generate strong demand over, larger area coverage benefits
• North America will remain at the forefront of the industry, given the higher risk of terrorism and domestic unrest in the United States

“Security inspections provide critical protection against threats such as unlawful and unethical actors against human life and property damage costs. Technologies such as biometric matching, X-ray scanners, and metal detectors, are popular at security checkpoints for optimizing scrutiny processes​,” says analyst at FMI.

Covid-19 Impact on Security Inspection Market

The coronavirus pandemic has exposed a wide range of sectors to substantial economic uncertainty owing to restricted operations, and strict social distancing guidelines. The security inspection market is witnessing lower demand, particularly in the transport sector. However, tech innovations could potentially generate key growth opportunities.

While physical distancing becoming the norm, institutions using security inspections are displaying interest towards automated systems, and self-service products to minimize touchpoints to minimize human to human interactions.

Consequently, the advancements in AI and data analytics will help in managing the recovery of the end user sectors such as defense and aviation in terms of traffic growth, airport infrastructure, passenger expectations, and changing security threats.

Competitive Intelligence

Some of the key players in the security inspection market include Leidos, Gilardoni S.p.A., Nuctech Company Ltd., Analogic Corporation, Smiths Group plc, ADANI, Rapiscan Systems, Unival group GmbH, EAS Envimet Analytical Systems GmbH, Bruker, and C.E.I.A. SpA. With the competitive nature of the market landscape, product development and launch strategies, and efforts towards regulatory approval are key strategies.

• The Kylin Ti computed tomography imaging scanner by Nuctech Company Limited has received the European Civil Aviation Conference’s certification of Explosive Detection System for Cabin Baggage (EDSCB) designation.
• The US Transport Security Administration (TSA) has added the EMIS series electromagnetic cargo screening systems to its official list of Air Cargo Qualified technologies, for potential terrorism threats and to detect contraband and restricted goods.

Ask An Analyst @ https://www.futuremarketinsights.com/ask-the-analyst/rep-gb-12422

Key Segments

Product

• Personnel Screening Systems
• Checkpoint Screening Systems
• Explosives & Drugs Trace Detection Systems
• Liquid and Radioactive Substance Monitors,
• Cargo and Baggage Inspection Systems
• Vehicle Inspection Systems
• Others

Type

• Portable
• Fixed

Application

• Aviation
• Border Security
• Correctional Facilities and Law Enforcement
• Critical Infrastructure Protection
• Commercial Security
• Others

Service

• Security Consulting Services
• Installation and Integration Services
• Maintenance and Repair Services
• Security Training Services
• Support Services

More About Security Inspection Market?

A new market research report published by Future Market Insights (FMI) on the global security inspection market offers key insights into the market trends and analysis of critical opportunities through the assessment period, 2022-2030. The report studies the security inspection market through five unique segments – product, type, application, service, and region. The security inspection market report also provides detailed assessment of sales through market dynamics, life cycle analysis, and technologies that are being deployed in the development of security inspection product and services across varying end-use sectors.

Related Reports –

https://globalsocials.mn.co/posts/22556132

https://community.growthhackers.com/posts/smart-spaces-market-latest-research-industry-analysis-driver-trends-business-overview-key-value-demand-and-forecast-2022-2032

https://faceblox.mn.co/posts/22556135

https://drujrake.mn.co/posts/22556138

https://speaknow.tribe.so/post/smart-spaces-market-key-players-applications-outlook-swot-analysis-and-fore–6257c5d50527b34948580ab0

Contact Us:
Future Market Insights
Unit No: 1602-006
Jumeirah Bay 2
Plot No: JLT-PH2-X2A
Jumeirah Lakes Towers
Dubai
United Arab Emirates
LinkedIn| Twitter| Blogs

Increasing awareness about various benefits of cold laser therapy is encouraging the adoption of cold laser or low-level laser therapy devices. Application of cold laser therapy in pain relief, treatment of musculoskeletal conditions, and nerve regeneration is increasing the sales in the market. These devices are increasingly installed in home care settings to offer relief from pain or inflammation to patients.

Due to increasing penetration of social media, people of all age groups are becoming overtly anxious about improving their appearance. Hence, the cold laser therapy market is rapidly growing owing to the growing interest in surgically improving appearance.

According to the World Health Organization (WHO), the global population of those above 65 years of age is expected to increase from nearly 1.0 billion in 2018 to around 2.1 billion by 2050 across the world.

For in-depth insights, Download a PDF Brochure – https://www.futuremarketinsights.com/reports/brochure/rep-gb-3639

With increasing demand from elder population as their skin is more prone to wrinkles, fine lines, flaccid skin, and other conditions, demand for cosmetic procedures is expected to surge.

Emerging nations such as India, China, Brazil, Russia, Mexico, and South Africa are offering ample of growth opportunities for cold laser therapy devices market. One of the major factor for increased growth is rising prevalence of chronic diseases in the countries.

Exhibiting high demand for cold laser therapy to treat chronic pains, developing nations are likely to emerge as hotspot for cold laser therapy devices manufacturers.

Increasing research and development activities for innovation of novel technology and implementation of favorable reimbursement schemes in most developed countries is another factor fueling sales.

As per the report, key manufacturers are strengthening their supply chains particularly in regions such as Asia Pacific, Latin America and Middle East & Africa. Agreements, partnerships, and collaborations have emerged as key growth strategies adopted by leading players to expand their regional expansion and product portfolio.

For instance, in September, 2019, MedShift announced the 5-Year Strategic collaboration with BTL Aesthetics.  The partnership will boost the presence of Emsculpt® device, the first and only technology to non-invasively harness high-intensity electromagnetic energy to firm muscle for a more toned figure.

To remain ahead of your competitors, request for a sample – https://www.futuremarketinsights.com/reports/sample/rep-gb-3639

Key Takeaways from Cold Laser Therapy Market Study

• In terms of product, continuous laser devices will account for the largest market share in 2021.
• Single wavelength technology will hold the lion’s share in cold laser therapy market. The segment will account for more than 65% of total market share in 2021.
• Application of cold laser therapy devices in dermatology will generate highest revenue. As per FMI, the application is expected to account for more than 35% of value share in 2021.
• Specialty clinics are expected to be the primary end-users on the back on increasing demand for cold laser therapy for cosmetic procedures. The segment will contribute over 42% of market revenue in 2021.
• North America is expected to account for dominant 40.0% in the global market in 2021, with the U.S. spearheading growth in the region.

 “Growing demand for aesthetic cosmetic procedures and preference for non-invasive equipment have encouraged the key players to invest more in research activities to develop advanced devices. This is expected to create growth opportunities for market players, especially in East and South Asia as demand for cosmetic procedure and pain management is at all-time high,” says the FMI Analyst

Who is Winning?Some of the leading manufacturers of cold laser therapy market are focusing on product launches,  collaborations, and expansion strategies to enhance their market presence. For instance,

• In March 2021, Good Energies Ltd developed and sold the B-Cure Laser for pain relief and launched a new media campaign in collaboration with Guerillascope for creating awareness against chronic pain.
• In November, 2020, DJO Global, Inc. announced the launch of 25W LightForce Xpi to allow clinicians to treat pain and inflammation and aid in post-activity recovery with greater accuracy, providing more consistent outcomes for patients.
• In January 2020, BTL launched a new product BTL-6000 Traction Therapy for relieving patients from pain. The company strengthened its presence in the pain management market with this launch.
• In May 2019, Theralase Technologies Inc. announced its plan to expand its photodynamic therapy technology (PDT) into China after receiving necessary regulatory approval from the country.
• In May 2019, Erchonia Corporation announced the launch of Lunula Laser in the Korean market. It was a non-thermal and non-invasive device with low-level laser technology for foot fungus.
• In January 2020, Lexington International, LLC announce the launch of its innovative product Flip 80 Laser Cap to treat pattern hair loss and stimulate hair growth

The key market players profiled by FMI include Apira Science Inc., BioLight Technologies LLC, B-Cure laser Australia, Erchonia Corporation, Theralase Inc., THOR Photomedicine Ltd, DJO Global, Inc., BTL, Spectro Analytic Irradia AB, Photomedex.

Get a Tailored Made Report to Match Your requirements, Ask from Market Research Expert – https://www.futuremarketinsights.com/ask-question/rep-gb-3639

Cold Laser Therapy Market by Category By Product:

• Continuous Laser Devices
• Pulse Laser Devices
• Combination Laser Devices

By Technology:

• Single Wavelength Cold Laser Therapy Devices
• Multiple Wavelength Cold Laser Therapy Devices

By Application:

• Pain Management
• Arthritis
• Wound Healing
• Nerve Regeneration
• Dermatology
• Musculoskeletal
• Others

By End User:

• Hospitals
• Specialty Clinics
• Ambulatory Surgical Centers
• Homecare Settings

For in-depth insights, Download a PDF Brochure – https://www.futuremarketinsights.com/reports/brochure/rep-gb-3639

By Region:

• North America
• Latin America
• Europe
• East Asia
• South Asia
• Oceania
• Middle East and Africa (MEA)

Data Virtualization Cloud Market Size Study

• Standalone software to remain preferable component in data visualization cloud market
• Business intelligence tools to account for greater data consumption through 2030
• Public cloud model continues to generate significant demand over following decade
• Market players continue to view BFSI industry as target customer of data visualization cloud solutions
• Markets in North America and Europe will remain in vanguard, given presence of key players and well-established cloud infrastructure

“Cloud-based models have become commonplace and companies are strategically leveraging them to upgrade their applications for data-driven architecture. With this maturity, digital transition and subsequent cloud adoption has become substantially manageable than ever before. Innovative trends are coming forth to support slew of use cases in hybrid and multi-cloud ecosystems,” says analyst at FMI.

COVID-19 Impact on Data Virtualization Cloud Market

While the COVID-19 pandemic has exposed almost every industry to economic uncertainties, the global data virtualization cloud market has emerged in a position of strength from the pandemic.

With physical interaction no longer an acceptable form of communication in wake of social distancing measures, institutions and enterprises across the globe have implemented sudden shifts to digital solutions in order to mimic pre-crisis growth levels.

Companies from other industries are realizing the benefits and potential of cloud-based solutions, even ahead the immediate need for remote working triggered by COVID-19 pandemic. Many enterprises will kick start ramping up their digital transition efforts and invest heftily in cloud and IT resources in coming years.

As such, it appears highly unlikely that the public health crisis will affect bottom lines of players in data virtualization cloud market to significant degree.

Ask An Analyst @ https://www.futuremarketinsights.com/ask-the-analyst/rep-gb-12414

Data Virtualization Cloud Market – Competitive Intelligence

Presence of technology giants such as Microsoft Corporation, IBM Corporation, and SAP has intensified competitive landscape of global data virtualization cloud market. In order to survive cut-throat competition, market players are bringing advancements in existing solutions as well as are offering them at flexible pricing. For instance,

• Microsoft Corporation has developed Conduit, which is lightweight data virtualization solution that offers direct query to various data sources irrespective of their location though centralized security framework that allows de-centralized access while fulfiling five Cs – Combine, Connect, Collaborate, and Consume with Compliance.
• Taking advantages of Google Cloud’s flexible rent-by-hour licensing format, Denodo has developed platform for Google Cloud Platform (GCP) that is available at broad array of pricing options including number of data sources. Denodo Platform for GCP provides features identical to the elite Denodo Platform. Furthermore, Denodo Platform can be deployed on GCP as bring your own license (BYOL).

Want to Know More About Data Virtualization Cloud Market?

A new market research report published by Future Market Insights (FMI) on the global data virtualization cloud market report offers comprehensive insights into the market demand trends and analysis of opportunities over the forecast period, 2020-2030. The report examines the data virtualization cloud market through five different segments – component, data consumer, deployment model, end-use industry, and region. The data virtualization cloud market report also provides extensive assessment of pricing by different key market dynamics, life cycle analysis, and technologies that are being deployed in the development of data virtualization cloud and product adoption across several end-use industries.

Related Reports –

https://www.reddit.com/user/tanmayb4733/comments/u3b6gx/smart_spaces_market_is_growing_at_a_cagr_of_162/

https://tanmayb.livejournal.com/5427.html

https://flipboard.com/@rahulverma3fha/smart-spaces-market-2022-size-growth-analysis-report-forecast-to-2032-qq08d3umy

https://hackmd.io/@tanmayb4733/HJuvMrr4q

https://acatpg.mn.co/posts/22556131

Contact Us:
Future Market Insights
Unit No: 1602-006
Jumeirah Bay 2
Plot No: JLT-PH2-X2A
Jumeirah Lakes Towers
Dubai
United Arab Emirates
LinkedIn| Twitter| Blogs

North America is expected to contribute a high revenue share in the global aortic stent grafts market over the forecast period. North America is witnessing a large demand for aortic stent grafts due to high adoption of endovascular repair surgeries, which is expected to boost the growth of the aortic stent grafts market.

The global market is segmented based on product type, end users and region. Based on the product type the market is segmented into abdominal aortic stent graft and thoracic aortic stent grafts. Abdominal aortic stent graft product type segment is expected to represent high revenue share in the global aortic stent grafts market. The thoracic aortic stent graft segment is expected to gain significant share in the forecast period due to increasing focus of the manufacturers on product launch for TEVAR procedures. Based on end users, the market is segmented into the hospitals and ambulatory surgical centers/outpatient surgical centers. Among both the end users, the hospitals is expected to be the leading segment the market.

To remain ahead of your competitors, request for a sample – https://www.futuremarketinsights.com/reports/sample/rep-gb-865

New product launches with improved stent graft designs are expected to provide enormous opportunities for the growth of the aortic stent grafts market and fulfil the demand from surgeons to overcome complications during surgeries. Increasing government initiatives to reduce the burden of abdominal aortic aneurysm, favourable recommendation and regulatory approvals, mergers, and acquisitions among manufacturers are the key market trends, which are expected to boost the growth of aortic stent grafts market.

Increasing prevalence of aortic aneurysm among the older population, favourable reimbursement policies, adoption of new minimally invasive technologies are the major factors expected to impel the growth of the aortic stents grafts market. Increasing number of government screening programs for people over 65 age has provided huge growth opportunities for the manufacturers operating in the aortic stent grafts market. However, product recalls and lack of skilled healthcare professionals are factors hindering the growth of the aortic stent grafts market.

Get a Tailored Made Report to Match Your requirements, Ask from Market Research Expert – https://www.futuremarketinsights.com/ask-question/rep-gb-865

The market for aortic stent grafts market is consolidated with large number of major players operating in the global market. Examples of some of the key players identified in global aortic stent grafts market are

• Cook Medical Inc.
• W.L. Gore & Associates
• MicroPort Scientific Corporation Inc.
• Medtronic Plc.
• Lombard Medical Inc.
• Endologix
• INC.
• Terumo Corporation Inc.
• Cardinal Health Inc.
• Becton
• Dickinson and Company
• Cryolife Inc.
• Lombard Medical Inc.

Aortic Stents Grafts Market By Category

Product Type:

• Abdominal Aortic Stent Graft
• Thoracic Aortic Stent Graft

End User:

• Hospitals
• Ambulatory Surgical Centers/Outpatient Surgical Centers